mRNA Vaccines Pose Grave Risks During Pregnancy, Suggests New Research

Recent studies have provided new insights into the safety of COVID-19 vaccines — particularly mRNA vaccines — during pregnancy. These studies document potential risks associated with vaccine administration in this demographic, requiring an urgent reevaluation of current recommendations.

Pfizer's own 5.3.6 post-market analysis and data from the Vaccine Adverse Event Reporting System (VAERS) have documented significant adverse events following vaccination, including an unexpectedly high rate of miscarriages and other pregnancy complications. This data calls into question the initial safety assurances provided to the public.

Moreover, a groundbreaking study published in the American Journal of Obstetrics & Gynecology (AJOG) in January 2024 found that mRNA vaccine components could cross the placental barrier, reaching both the placenta and fetal blood.

This contradicts a 2022 study entitled "Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy," which initially found no evidence of mRNA vaccines crossing the placental barrier.

I’m sure it’s merely a coincidence that the University of California, San Francisco (UCSF) and the San Francisco J. Gladstone Institute (institutions associated with the study’s authors) have received millions of federal dollars. In fact, on its website, UCSF proudly proclaims the university has “received the most funding from the National Institutes of Health (NIH) of any public university in 2023,” later adding that “it is the 17th year in a row that UCSF has earned this distinction among public institutions.”

Medical Decisions Should Be Objective

Putting aside motives, however, this "evolution" in scientific knowledge underscores the need for continuous research and the obligation to approach vaccine safety with an open mind, ready to adapt recommendations based on the latest evidence — regardless of what that evidence suggests.

Given the profound implications these new findings have for fetal safety and the potential long-term impacts on the human genome, there is a strong argument for pausing the administration of COVID-19 vaccines to pregnant individuals. This would allow for thorough, independent, and transparent research to ascertain whether the vaccines are safe for this sensitive population.

Same Old, Same Old

Unfortunately, the latest evidence has done little to change the messaging from mainstream media types and health organizations, which once proclaimed we should “follow the science” and now seem determined to ignore it.

The Centers for Disease Control and Prevention (CDC) website still claims — in bold type, no less — that "COVID-19 vaccination during pregnancy is safe and effective."

Not to be outdone, the World Health Organization (WHO) notes (also in bold type) that "the benefits of vaccination during pregnancy outweigh potential risks."

What Needs to Be Done

It is my opinion that these genetic therapies must never be re-implemented in pregnancy until valid, independent, randomized, double-blind, placebo-controlled trials assess long-term risks. Until this moratorium takes place, informed consent should require pregnant patients to be informed that long-term risks to the fetus are unknown.

To suggest otherwise is to put pregnant individuals — and their babies — in jeopardy, and that is unacceptable.

Please visit America Out Loud News for more in-depth information on this topic.

Sincerely,